A seguir

Reprodução automática

Challenges in treating cancers of unknown primary (CUP)

7 Visualizações • 06/16/23
Compartilhar
Embutir
administrator
administrator
Assinantes
0

Thomas Helleday, MD, PhD, Karolinska Institute, Stockholm, Sweden & University of Sheffield, Sheffield, UK, highlights the issues with treating cancers of unknown primary (CUP), which result in a poor prognosis for patients. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Mostre mais
0 Comentários sort Ordenar por
Comentários do Facebook

A seguir

Reprodução automática